Chlamydia pneumoniae infection after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 2, 2005, Pages 131-136

  Glanville, Allan R ^a   Gencay, Mesut ^a   Tamm, Michael ^a   Chhajed, Prashant ^a   Plit, Marshall ^a   Hopkins, Peter ^a   Aboyoun, Christina ^a   Roth, Michael ^a   Malouf, Monique ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CAUSE OF DEATH; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEALTH SURVEY; HUMAN; LAVAGE; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PNEUMONIA; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RESPIRATORY TRACT DISEASE; SURVIVAL TIME; TRANSBRONCHIAL BIOPSY;

EID: 13444310880     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.09.042     Document Type: Article

References (39)

1. File T.M. Jr, Tan J.S., Plouffe J.F. The role of atypical pathogens Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin N Am. 12:1998;569-592
2. Hagiwara K., Ouchi K., Tashiro N., Azuma M., Kobayashi K. An epidemic of a pertussis-like illness caused by Chlamydia pneumoniae. Pediat Infect Dis J. 18:1999;271-275
3. Heiskanen-Kosma T., Korppi M., Laurila A., Jokinen C., Kleemola M., Saikku P. Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children serological results of a prospective, population-based study. Scand J Infect Dis. 31:1999;255-259
4. von Hertzen L. Role of persistent infection in the control and severity of asthma focus on Chlamydia pneumoniae. Eur Respir J. 19:2002;546-556
5. Gencay M., Rudiger J.J., Tamm M., Soler M., Perruchoud A.P., Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med. 163:2001;1097-1100
6. Hahn D.L., McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann Allergy Asthma Immunol. 81:1998;339-344
7. Black P.N., Scicchitano R., Jenkins C.R., et al. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J. 15:2000;254-259
8. Blasi F., Legnani D., Lombardo V.M., et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J. 6:1993;19-22
9. Hahn D.L. Chlamydia pneumoniae, asthma, and COPD what is the evidence? Ann Allergy Asthma Immunol. 83:1999;271-288
10. Hansen E.F., Vestbo J., Phanareth K., Kok-Jensen A., Dirksen A. Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 163:2001;690-693
11. Karnak D., Beng-sun S., Beder S., Kayacan O. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med. 95:2001;811-816
12. Jantos C.A., Roggendorf R., Wuppermann F.N., Hegemann J.H. Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay. J Clin Microbiol. 36:1998;1890-1894
13. Hammerschlag M.R. Chlamydia pneumoniae and the lung. Eur Respir J. 16:2000;1001-1007
14. Wang S. The microimmunofluorescence test for Chlamydia pneumoniae infection technique and interpretation. J Infect Dis. 181:(suppl 3):2000;S421-S425
15. Messmer T.O., Martinez J., Hassouna F., et al. Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae. Clin Diagn Lab Immunol. 8:2001;588-592
16. Peeling R.W., Wang S.P., Grayston J.T., et al. Chlamydia pneumoniae serology interlaboratory variation in microimmunofluorescence assay results. J Infect Dis. 181:(suppl 3):2000;S426-S429
17. Verkooyen R.P., Willemse D., Hiep-van Casteren S.C., et al. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Clin Microbiol. 36:1998;2301-2307
18. Dowell S.F., Peeling R.W., Boman J., et al. Standardizing Chlamydia pneumoniae assays recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Center for Disease Control (Canada). Clin Infect Dis. 33:2001;492-503
19. Corsaro D., Valassina M., Venditti D., Venard V., Le Faou A., Valensin P.E. Multiplex PCR for rapid and differential diagnosis of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory infections. Diagn Microbiol Infect Dis. 35:1999;105-108
20. Mygind T., Birkelund S., Falk E., Christiansen G. Evaluation of real-time quantitative PCR for identification and quantification of Chlamydia pneumoniae by comparison with immunohistochemistry. J Microbiol Meth. 46:2001;241-251
21. Mahony J.B., Chong S., Coombes B.K., Smieja M., Petrich A. Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells. J Clin Microbiol. 38:2000;2622-2627
22. Apfalter P., Blasi F., Boman J., et al. Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol. 39:2001;519-524
23. Hammerschlag M.R. Asymptomatic respiratory infection with Chlamydia pneumoniae what does it mean? Chest. 119:2001;1303-1305
24. Blasi F., Cosentini R., Schoeller M.C., Lupo A., Allegra L. Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan. Thorax. 48:1993;1261-1263
25. Heinemann M., Kern W.V., Bunjes D., Marre R., Essig A. Severe Chlamydia pneumoniae infection in patients with neutropenia case reports and literature review. Clin Infect Dis. 31:2000;181-184
26. Glanville A.R. Current and prospective treatments of obliterative bronchiolitis. Curr Opin Org Transplant. 5:2000;396-401
27. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The registry of the International Society for Heart and Lung Transplantation eighteenth official report - 2001. J Heart Lung Transplant. 20:2001;805-815
28. Husain A.N., Siddiqui M.T., Reddy V.B., Yeldandi V., Montoya A., Garrity E.R. Postmortem findings in lung transplant recipients. Mod Pathol. 9:1996;752-761
29. Glanville A.R., Marshman D., Keogh A., et al. Outcome in paired recipients of single lung transplants from the same donor. J Heart Lung Transplant. 14:1995;878-882
30. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001 an update of the diagnostic criteria. J Heart Lung Transplant. 21:2002;297-310
31. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection Lung Rejection Study Group. J Heart Lung Transplant. 15:1996;1-15
32. Redecke V., Dalhoff K., Bohnet S., Braun J., Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages infection and inflammatory response. Am J Respir Cell Molec Biol. 19:1998;721-727
33. Bin X.X., Wolf K., Schaffner T., Malinverni R. Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. Antimicrob Agents Chemother. 44:2000;1761-1764
34. Numazaki K., Sakamoto Y., Umetsu M., et al. Therapeutic effect of clarithromycin for respiratory-tract infections in children caused by Chlamydia pneumoniae. Research Group of Sapporo for Pediatric Chlamydial Infections. Int J Antimicrob Agents. 13:2000;219-222
35. Orfila J. Antibiotic susceptibility of Chlamydia pneumoniae. J Infect Dis. 181:(suppl 3):2000;S455
36. Burke C.M., Glanville A.R., Theodore J., Robin E.D. Lung immunogenicity, rejection, and obliterative bronchiolitis. Chest. 92:1987;547-549
37. Wu L., Skinner S.J., Lambie N., Vuletic J.C., Blasi F., Black P.N. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 162:2000;1148-1151
38. Morrison R. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease. Sem Immunol. 3:1991;25-33
39. + lymphocytes by inhibiting IL-2 production. J Immunol. 160:1998;2231-2237